Reading medical firm Occuity launches crowdfunding opportunity
Occuity, a quickly expanding MedTech business based out of Reading, is starting a new round of crowdfunding investment in order to raise the funds it needs to market its highly innovative, non-contact screening, monitoring and ophthalmic products. Including the non-invasive glucose monitoring device known as 'Occuity Indigo'.
The Berkshire company is starting its equity crowdfunding campaign through Seedrs, a start-up-focused company with its HQ in East London's Tech City. Seedrs is one of the top crowdsourcing seed and angel investment companies in Europe.
The capital investment during this crowdfunding campaign will not only help accelerate the research and development of their revolutionary optical devices that help screen and monitor common diseases affecting more than a billion people worldwide. It will also will enable Occuity to capitalise on a significant new opportunity - the development of a handheld device for measuring axial length in myopia management.
Investors will become an equity shareholder in Occuity. You can invest as little as £24, with no upper limit on investment amounts.
You can find out more about the investment opportunity here.
Main picture: Occuity/Seedrs
READ MORE: savvy navvy hits Seedrs target on same day as crowdfunding launch
READ MORE: Boyes Turner advises Occuity on its £2 million crowdfunding round
